Bioethics

1 Appleby, John B. 2015. The ethical challenges of the clinical introduction of mitochondrial replacement techniques. Medicine, Health Care and Philosophy 18 (4): 501–14.

2 Araki, Motoko, and Tetsuya Ishii. 2014. International regulatory landscape and integration of corrective genome editing into in vitro; fertilization. Reproductive Biology and Endocrinology 12 (1): 1–12.

3 Asch, Adrienne, and Dorit Barlevy. 2012. Disability and genetics: A disability critique of pre‐natal testing and pre‐implantation genetic diagnosis (PGD). In Encyclopaedia of life science, eLS. Chichester: Wiley.

4 Baltimore, David, Paul Berg, Michael Botchan, Dana Carroll, R. Alta Charo, George Church, Jacob E. Corn, et al. 2015. A prudent path forward for genomic engineering and germline gene modification. Science 348 (6230): 36–8.

5 Barnes, Elizabeth. 2014. Valuing disability, causing disability. Ethics 125 (1): 88–113.

6 Biondi, Stefano. 2013. Access to medical‐assisted reproduction and PGD in Italian law: A deadly blow to an illiberal statute? Commentary to the European Court on Human Rights’s decision Costa and Pavan v Italy (ECtHR, 28 August 2012, App. 54270/2010). Medical Law Review 21 (3): 474–86.

7 Brokowski, Carolyn, Marya Pollack, and Robert Pollack. 2015. Cutting eugenics out of CRISPR‐Cas9. Ethics in Biology, Engineering and Medicine: An International Journal 6 (3–4): 263–79.

8 Buchanan, Allen. 1996. Choosing who will be disabled: Genetic intervention and the morality of inclusion. Social Philosophy and Policy 13 (2): 18–46.

9 Buchanan, Allen. 2008. Enhancement and the ethics of development. Kennedy Institute of Ethics Journal 18 (1): 1–34.

10 Buchanan, Allen. 2011. Beyond humanity?: The ethics of biomedical enhancement. Oxford: Oxford University Press.

11 Buchanan, Allen, Dan W. Brock, Norman Daniels, and Daniel Wikler. 2001. From chance to choice: Genetics and justice. Cambridge: Cambridge University Press.

12 Camporesi, Silvia, and Giulia Cavaliere. 2016. Emerging ethical perspectives in the clustered regularly interspaced short palindromic repeats genome‐editing debate. Personalized Medicine 13 (6): 575–586.

13 Cavaliere, Giulia. 2017. A 14‐day limit for bioethics: The debate over human embryo research. BMC Medical Ethics 18 (1): 38.

14 Collins, Francis S. 2015. Statement on the NIH funding of research using gene‐editing technologies in human embryos. National Institute of Health (NIH) http://www.nih.gov/about‐nih/who‐we‐are/nih‐director/statements/statement‐nih‐funding‐research‐using‐gene‐editing‐technologies‐human‐embryos. Accessed 12 July 2017.

15 Dupras, Charles, Vardit Ravitsky, and Bryn Williams‐Jones. 2014. Epigenetics and the environment in bioethics. Bioethics 28 (7): 327–34.

16 Dworkin, Gerald. 1982. Is more choice better than less? Midwest Studies in Philosophy 7 (1): 47–61.

17 Emanuel, Ezekiel J., David Wendler, and Christine Grady. 2000. What makes clinical research ethical? JAMA 283 (20): 2701–11.

18 Gianaroli, Luca, Anna Pia Ferraretti, Maria Cristina Magli, and Serena Sgargi. 2016. Current regulatory arrangements for assisted conception treatment in European countries. European Journal of Obstetrics & Gynecology and Reproductive Biology 207: 211–13.

19 Gyngell Christopher, Thomas, Douglas, and Julian, Savulescu. 2016. The ethics of germline gene editing. Journal of Applied Philosophy 34 (3): 1–16.

20 Harris, John. 1992. Wonderwoman & superman: Ethics & human biotechnology. Oxford: Oxford University Press.

21 Harris, John. 2010. Enhancing evolution: The ethical case for making better people. Princeton: Princeton University Press.

22 Harris, John. 2016. Germline modification and the burden of human existence. Cambridge Quarterly of Healthcare Ethics 25 (1): 6–18.

23 Heo, Young Tae, Xiaoyuan Quan, Yong Nan Xu, Soonbong Baek, Hwan Choi, Nam‐Hyung Kim, and Jongpil Kim. 2014. CRISPR/Cas9 nuclease‐mediated gene knock‐in in bovine‐induced pluripotent cells. Stem Cells and Development 24 (3): 393–402.

24 Hyun, Insoo, Amy Wilkerson, and Josephine Johnston. 2016. Embryology policy: Revisit the 14‐day rule. Nature 533 (7602): 169–71.

25 Jasanoff, Sheila, J. Benjamin Hurlbut, and Krishanu Saha. 2015. CRISPR democracy: Gene editing and the need for inclusive deliberation. Issues in Science and Technology 32 (1): 37–49.

26 Kitcher, Philip. 2001. Science, truth and democracy. New York: Oxford University Press.

27 Knoppers, Bartha M., Sylvie Bordet, and Rosario M. Isasi. 2006. Preimplantation genetic diagnosis: An overview of socio‐ethical and legal considerations. Annual Review of Genomics and Human Genetics 7: 201–21.

28 Lander, Eric S. 2015. Brave new genome. New England Journal of Medicine 373 (1): 5–8.

29 Lanphier, Edward, and Fyodor Urnov. 2015. Don’t edit the human germ line. Nature 519 (7544): 410.

30 Liao, S. Matthew. 2017. Do mitochondrial replacement techniques affect qualitative or numerical identity? Bioethics 31 (1): 20–6.

31 Liu, Yunhong, Xiaoyan Lv, Ruizhi Tan, Tianming Liu, Tielin Chen, Mi Li, and Yuhang Liu, et al. 2014. A modified TALEN‐based strategy for rapidly and efficiently generating knockout mice for kidney development studies. PLoS ONE 9 (1): e84893.

32 MacKellar, Calum, and Christopher Bechtel. 2014. The ethics of the new eugenics. New York: Berghahn Books.

33 McMahan, Jeff. 2006. Is prenatal genetic screening unjustly discriminatory? Virtual Mentor 8 (1): 50–2.

34 Niu, Jingwen, Bin Zhang, and Hu Chen. 2014. Applications of TALENs and CRISPR/Cas9 in human cells and their potentials for gene therapy. Molecular Biotechnology 56 (8): 681–8.

35 Nuffield Council on Bioethics. 2016. Genome editing: An ethical review. London: Nuffield Council on Bioethics.

36 Palacios‐González, César. 2017. Are there moral differences between maternal spindle transfer and pronuclear transfer? Medicine, Health Care and Philosophy. doi:10.1007/s11019‐017‐9772‐3.

37 Parens, Erik, and Adrienne Asch. 2003. Disability rights critique of prenatal genetic testing: Reflections and recommendations. Mental Retardation and Developmental Disabilities Research Reviews 9 (1): 40–7.

38 Parfit, Derek. 1984. Reasons and persons. Oxford: Oxford University Press.

39 Paul, Diane B. 1992. Eugenic anxieties, social realities, and political choices. Social Research 59 (3): 663–83.

40 Pennings, Guido, Guido de Wert, Francoise Shenfield, Jacques Cohen, Basil Tarlatzis, and Paul Devroey. 2007. ESHRE Task Force on Ethics and Law 13: The welfare of the child in medically assisted reproduction. Human Reproduction 22 (10): 2585–8.

41 Reyes, Alvaro P., and Fredrik Lanner. 2017. Towards a CRISPR view of early human development: Applications, limitations and ethical concerns of genome editing in human embryos. Development (Cambridge, England) 144 (1): 3–7.

42 Robertson, John A. 1996. Children of choice: Freedom and the new reproductive technologies. Princeton: Princeton University Press.

43 Rose, Nikolas. 1999. Powers of freedom: Reframing political thought. Cambridge: Cambridge University Press.

44 Rothman, Barbara Katz. 1985. The products of conception: The social context of reproductive choices. Journal of medical ethics 11 (4): 188–95.

45 Rulli, Tina. 2016a. The mitochondrial replacement ‘therapy’ myth. Bioethics. doi:10.1111/bioe.12332.

46 Rulli, Tina. 2016b. What is the value of three‐parent IVF? Hastings Center Report 46 (4): 38–47.

47 Scott, Rosamund. 2006. Choosing between possible lives: Legal and ethical issues in preimplantation genetic diagnosis. Oxford Journal of Legal Studies 26 (1): 153–78.

48 Shakespeare, Tom. 2006. Disability rights and wrongs. New York: Routledge.